Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs Immunovant Inc. Common Stock — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.26 (market cap $39.95B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 6× Immunovant Inc. Common Stock's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.2% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| HLN | IMVT | |
|---|---|---|
Market Cap | $39.95B | $6.62B |
Volume | 18,243,581 | 1,131,364 |
Sector | Health | Health |
52-Week High | $11.27 | $44.96 |
52-Week Low | $8.70 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $49.77B | $5.72B |
Dividend Yield | 2.2% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →